Binosto
Active substance: alendronate
TABLET, EFFERVESCENT · ALENDRONATE SODIUM 91.37 mg/1
United StatesActive
Marketing holder: Radius Health, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ALENDRONATE SODIUM · 91.37 mg/1
Registration
- Registration number
- 70539-400
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 70539-400 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70539-400 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70539-400 · Verified 2026-10-09 · open in source